Corvus Pharmaceuticals, Inc. Warrants and Rights Outstanding
Corvus Pharmaceuticals, Inc. (CRVS) had Warrants and Rights Outstanding of $3.78 million as of 2025-03-31, per its 10-Q filed 2025-05-08.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:WarrantsAndRightsOutstanding · last filed 2026-03-12
- 2025-03-31: Warrants and Rights Outstanding $3.78M.
- 2024-12-31: Warrants and Rights Outstanding $28.91M.
- 2024-09-30: Warrants and Rights Outstanding $39.96M.
- 2024-06-30: Warrants and Rights Outstanding $7.12M.
| Period end | Warrants and Rights Outstanding |
|---|---|
| 2025-03-31 | $3.78M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $28.91M 10-K · filed 2026-03-12 |
| 2024-09-30 | $39.96M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $7.12M 10-Q · filed 2024-08-06 |
| 2024-05-06 | $8.90M 10-Q · filed 2024-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Apnimed, Inc. (APMD) | United States | $0.899B |